Does the DPP4 Inhibitor (Sitagliptin) Increase Endometrial Mesenchymal Stem Cells in Women with Recurrent Miscarriage?
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Acronyms SIMPLANT
- 02 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 New trial record